Hbk Investments L P Enanta Pharmaceuticals Inc Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $130,959 - $192,816	-1,600 Reduced 7.21%	20,600 $2.39 Million
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $1.07 Million - $1.7 Million	18,439 Added 490.27%	22,200 $1.8 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $171,689 - $223,290	3,761	3,761 $221,000

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $131M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.